Skip to main content

Does Drug Dose Impact Mortality Following PAD Treatment with Paclitaxel Coated Devices?


Michael R. Jaff, DO
Dr. Andrew Holden
DIRECTOR OF INTERVENTIONAL RADIOLOGY AUCKLAND HOSPITAL
Dr. Peter Schneider
PROFESSOR OF SURGERY IN THE DIVISION OF VASCULAR & ENDOVASCULAR SURGERY UNIVERSITY OF CALIFORNIA SAN FRANCISCO

Recent publications have debated the safety of paclitaxel when used to treat femoropopliteal disease and prevent restenosis.  We invite you to view this round table discussion where a panel of industry experts present and discuss new clinical information on the paclitaxel issue and mortality.

Back to Top